E1. Gu S, Glaug N, Cnaan A, Packer RJ, Avery R A. Ganglion Cell Layer-Inner Plexiform Layer

e-References

e1. Gu S, Glaug N, Cnaan A, Packer RJ, Avery R a. Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas. Invest Ophthalmol Vis Sci. 2014;55(3):1402-1408. doi:10.1167/iovs.13-13119.

e2. Parrozzani R, Clementi M, Kotsafti O, et al. Optical coherence tomography in the diagnosis of optic pathway gliomas. Invest Ophthalmol Vis Sci. 2013;54(13):8112-8118. doi:10.1167/iovs.13-13093.

e3. Fard MA, Fakhree S, Eshraghi B. Correlation of optical coherence tomography parameters with clinical and radiological progression in patients with symptomatic optic pathway gliomas. Graefes Arch Clin Exp Ophthalmol. 2013;251(10):2429-2436. doi:10.1007/s00417-013-2394-4.

e4. Trobe J, Glaser J, Cassady J, Herschler J, Anderson DR. Nonglaucomatous excavation of the optic disc. Arch …. 1980;98(6):1046-1050.

e5. Danesh-Meyer H V, Yap J, Frampton C, Savino PJ. Differentiation of compressive from glaucomatous optic neuropathy with spectral-domain optical coherence tomography. Ophthalmology. 2014;121(8):1516-1523. doi:10.1016/j.ophtha.2014.02.020.

e6. Danesh-Meyer H V, Papchenko T, Savino PJ, Law A, Evans J, Gamble GD. In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci. 2008;49(5):1879-1885. doi:10.1167/iovs.07-1127.

e7. Jacob M, Raverot G, Jouanneau E, et al. Predicting visual outcome after treatment of pituitary adenomas with optical coherence tomography. Am J Ophthalmol. 2009;147(1):64-70.e2. doi:10.1016/j.ajo.2008.07.016.

e8. Loo J-L, Tian J, Miller NR, Subramanian PS. Use of optical coherence tomography in predicting post-treatment visual outcome in anterior visual pathway meningiomas. Br J Ophthalmol. 2013;97(11):1455-1458. doi:10.1136/bjophthalmol-2013-303449.

e9. Contreras I, Noval S, Rebolleda G, Muñoz-Negrete FJ. Follow-up of Nonarteritic Anterior Ischemic Optic Neuropathy with Optical Coherence Tomography. Ophthalmology. 2007;114:2338-2345. doi:10.1016/j.ophtha.2007.05.042.

e10. Alasil T, Tan O, Lu AT, Huang D, Sadun A a. Correlation of Fourier domain optical coherence tomography retinal nerve fiber layer maps with visual fields in nonarteritic ischemic optic neuropathy. Ophthalmic Surg Lasers Imaging. 2008;39:S71-S79. doi:10.1016/j.bbi.2008.05.010.

e11. Papchenko T, Grainger BT, Savino PJ, Gamble GD, Danesh-Meyer H V. Macular thickness predictive of visual field sensitivity in ischaemic optic neuropathy. Acta Ophthalmol. 2012;90:463-469. doi:10.1111/j.1755-3768.2012.02467.x.

e12. Aggarwal D, Tan O, Huang D, Sadun A a. Patterns of ganglion cell complex and nerve fiber layer loss in nonarteritic ischemic optic neuropathy by fourier-domain optical coherence tomography. Investig Ophthalmol Vis Sci. 2012;53(8):4539-4545. doi:10.1167/iovs.11-9300.

e13. Rebolleda G, Sanchez-Sanchez C, Gonzalez-Lopez JJ, Contreras I, Munoz-Negrete FJ. Papillomacular Bundle and Inner Retinal Thicknesses Correlate With Visual Acuity in Nonarteritic Anterior Ischemic Optic Neuropathy. Invest Ophthalmol Vis Sci. 2015;56:682-692. doi:10.1167/iovs.14-15314.

e14. Zoumalan CI, Agarwal M, Sadun A a. Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol. 2005;243(5):410-416. doi:10.1007/s00417-004-1053-1.

e15. Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol. 2007;91(7):895-897. doi:10.1136/bjo.2006.113118.

e16. Kim Y-K, Hwang J-M. Serial retinal nerve fiber layer changes in patients with toxic optic neuropathy associated with antituberculosis pharmacotherapy. J Ocul Pharmacol Ther. 2009;25(6):531-535. doi:10.1089/jop.2009.0064.

e17. Türkyılmaz K, Öner V, Türkyılmaz AK, Kırbaş A, Kırbaş S, Şekeryapan B. Evaluation of peripapillary retinal nerve fiber layer thickness in patients with vitamin B12 deficiency using spectral domain optical coherence tomography. Curr Eye Res. 2013;38(6):680-684. doi:10.3109/02713683.2012.758291.

e18. Pandey S, Kalita J, Misra UK. A sequential study of visual evoked potential in patients with vitamin B12 deficiency neurological syndrome. Clin Neurophysiol. 2004;115(4):914-918. doi:10.1016/j.clinph.2003.11.013.

e19. Buncic JR, Westall C a, Panton CM, Munn JR, MacKeen LD, Logan WJ. Characteristic retinal atrophy with secondary “inverse” optic atrophy identifies vigabatrin toxicity in children. Ophthalmology. 2004;111(10):1935-1942. doi:10.1016/j.ophtha.2004.03.036.

e20. Wild JM, Robson CR, Jones AL, Cunliffe I a, Smith PEM. Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci. 2006;47(3):917-924. doi:10.1167/iovs.05-0854.

e21. Jain N, Bhatti MT. Fingolimod-associated macular edema: incidence, detection, and management. Neurology. 2012;78(9):672-680. doi:10.1212/WNL.0b013e318248deea.

e22. Zarbin M a, Jampol LM, Jager RD, et al. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology. 2013;120(7):1432-1439. doi:10.1016/j.ophtha.2012.12.040.

e23. Guo L, Duggan J, Cordeiro MF. Alzheimer’s disease and retinal neurodegeneration. Curr Alzheimer Res. 2010;7(1):3-14.

e24. Moschos MM, Markopoulos I, Chatziralli I, et al. Structural and functional impairment of the retina and optic nerve in Alzheimer’s disease. Curr Alzheimer Res. 2012;9(7):782-788.

e25. Gharbiya M, Trebbastoni A, Parisi F, et al. Choroidal thinning as a new finding in Alzheimer’s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis. 2014;40(4):907-917. doi:10.3233/JAD-132039.

e26. Kupersmith MJ, Shakin E, Siegel IM, Lieberman A. Visual system abnormalities in patients with Parkinson’s disease. Arch Neurol. 1982;39(5):284-286.

e27. Yu J-G, Feng Y-F, Xiang Y, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS One. 2014;9(1):e85718. doi:10.1371/journal.pone.0085718.

e28. Adam CR1, Shrier E, Ding Y, Glazman S B-WI. Journal of Neuro-Ophthalmology. :137-142.

e29. Garcia-Martin E, Larrosa JM, Polo V, et al. Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol. 2014;157(2):470-478.e2. doi:10.1016/j.ajo.2013.09.028.

e30. Roth NM, Saidha S, Zimmermann H, et al. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol. 2013;20(8):1170-1176. doi:10.1111/ene.12146.

e31. Ringelstein M, Albrecht P, Südmeyer M, et al. Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2014;1(4):290-297. doi:10.1002/acn3.46.

e32. Martinez a, Proupim N, Sanchez M. Retinal nerve fibre layer thickness measurements using optical coherence tomography in migraine patients. Br J Ophthalmol. 2008;92(8):1069-1075. doi:10.1136/bjo.2008.137471.

e33. Dadaci Z, Doganay F, Oncel Acir N, Aydin HD, Borazan M. Enhanced depth imaging optical coherence tomography of the choroid in migraine patients: implications for the association of migraine and glaucoma. Br J Ophthalmol. 2014;98(7):972-975. doi:10.1136/bjophthalmol-2013-304711.